Secondary Chemoprevention of Barrett’s Esophagus With Celecoxib: Results of a Randomized Trial

BACKGROUND: Barrett’s esophagus is a premalignant condition that is a risk factor for the development of esophageal adenocarcinoma, a disease whose incidence is rapidly increasing. Because aspirin and other nonsteroidal antiinflammatory drugs, such as celecoxib, may decrease the risk of developing e...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Heath, Elisabeth I., Canto, Marcia Irene, Piantadosi, Steven, Montgomery, Elizabeth, Weinstein, Wilfred M., Herman, James G., Dannenberg, Andrew J., Yang, Vincent W., Shar, Albert O., Hawk, Ernest, Forastiere, Arlene A.
Format: Artigo
Langue:Inglês
Publié: 2007
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3755596/
https://ncbi.nlm.nih.gov/pubmed/17405999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djk112
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires